473 related articles for article (PubMed ID: 35337340)
1. CRISPR based therapeutics: a new paradigm in cancer precision medicine.
Das S; Bano S; Kapse P; Kundu GC
Mol Cancer; 2022 Mar; 21(1):85. PubMed ID: 35337340
[TBL] [Abstract][Full Text] [Related]
2. Application of CRISPR-Cas systems in neuroscience.
Bonnerjee D; Bagh S
Prog Mol Biol Transl Sci; 2021; 178():231-264. PubMed ID: 33685599
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Gene Editing with CRISPR: A Laboratory Medicine Perspective.
Hahn E; Hiemenz M
Clin Lab Med; 2020 Jun; 40(2):205-219. PubMed ID: 32439069
[TBL] [Abstract][Full Text] [Related]
4. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
5. CRISPR based bacterial genome editing and removal of pathogens.
Jothi R; Karthika C; Kamaladevi A; Satish L; Pandian SK; Gowrishankar S
Prog Mol Biol Transl Sci; 2021; 179():77-92. PubMed ID: 33785178
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas systems: Challenges and future prospects.
Gohil N; Bhattacharjee G; Lam NL; Perli SD; Singh V
Prog Mol Biol Transl Sci; 2021; 180():141-151. PubMed ID: 33934835
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in stem cells and gene editing: Drug discovery and therapeutics.
Bayarsaikhan D; Bayarsaikhan G; Lee B
Prog Mol Biol Transl Sci; 2021; 181():231-269. PubMed ID: 34127195
[TBL] [Abstract][Full Text] [Related]
8. A review on CRISPR/Cas-based epigenetic regulation in plants.
Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
[TBL] [Abstract][Full Text] [Related]
9. CRISPR therapeutic tools for complex genetic disorders and cancer (Review).
Baliou S; Adamaki M; Kyriakopoulos AM; Spandidos DA; Panayiotidis M; Christodoulou I; Zoumpourlis V
Int J Oncol; 2018 Aug; 53(2):443-468. PubMed ID: 29901119
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
11. [CRISPR/Cas9 technology in disease research and therapy: a review].
Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
[TBL] [Abstract][Full Text] [Related]
12. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
13. The era of editing plant genomes using CRISPR/Cas: A critical appraisal.
Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT
J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
Li C; Brant E; Budak H; Zhang B
J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
[TBL] [Abstract][Full Text] [Related]
15. Concerns regarding 'off-target' activity of genome editing endonucleases.
Kadam US; Shelake RM; Chavhan RL; Suprasanna P
Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
[TBL] [Abstract][Full Text] [Related]
16. Probing the impact of chromatin conformation on genome editing tools.
Chen X; Rinsma M; Janssen JM; Liu J; Maggio I; Gonçalves MA
Nucleic Acids Res; 2016 Jul; 44(13):6482-92. PubMed ID: 27280977
[TBL] [Abstract][Full Text] [Related]
17. Genome Editing in Human Cells Using CRISPR/Cas Nucleases.
Wyvekens N; Tsai SQ; Joung JK
Curr Protoc Mol Biol; 2015 Oct; 112():31.3.1-31.3.18. PubMed ID: 26423589
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
19. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy.
Song X; Liu C; Wang N; Huang H; He S; Gong C; Wei Y
Adv Drug Deliv Rev; 2021 Jan; 168():158-180. PubMed ID: 32360576
[TBL] [Abstract][Full Text] [Related]
20. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.
Naeimi Kararoudi M; Hejazi SS; Elmas E; Hellström M; Naeimi Kararoudi M; Padma AM; Lee D; Dolatshad H
Front Immunol; 2018; 9():1711. PubMed ID: 30233563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
